U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076178
Company: EPIC PHARMA LLC
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
NIZATIDINE NIZATIDINE 150MG CAPSULE;ORAL Prescription AB No No
NIZATIDINE NIZATIDINE 300MG CAPSULE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/05/2002 ORIG-1 Approval Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/76178f.ta.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/11/2013 SUPPL-7 Labeling-Package Insert

Label is not available on this site.

07/31/2011 SUPPL-6 Labeling-Package Insert

Label is not available on this site.

NIZATIDINE

CAPSULE;ORAL; 150MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
NIZATIDINE NIZATIDINE 150MG CAPSULE;ORAL Prescription No AB 077314 DR REDDYS LABS LTD
NIZATIDINE NIZATIDINE 150MG CAPSULE;ORAL Prescription No AB 076178 EPIC PHARMA LLC
NIZATIDINE NIZATIDINE 150MG CAPSULE;ORAL Prescription No AB 090618 GLENMARK PHARMS INC
NIZATIDINE NIZATIDINE 150MG CAPSULE;ORAL Prescription No AB 075616 WATSON LABS

CAPSULE;ORAL; 300MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
NIZATIDINE NIZATIDINE 300MG CAPSULE;ORAL Prescription No AB 077314 DR REDDYS LABS LTD
NIZATIDINE NIZATIDINE 300MG CAPSULE;ORAL Prescription No AB 076178 EPIC PHARMA LLC
NIZATIDINE NIZATIDINE 300MG CAPSULE;ORAL Prescription No AB 090618 GLENMARK PHARMS INC
NIZATIDINE NIZATIDINE 300MG CAPSULE;ORAL Prescription No AB 075616 WATSON LABS
Back to Top